CASP3 and asthma: Lee et al. [74] demonstrated using a lung epithelial cell line and a mouse model of asthma that IGFBP-3 was able to inhibit inflammation by facilitating the activation of caspase 3/7 and caspase 8 which degraded IκBα and p65, reducing TNF-induced inflammation.